MedPath

Fragmin

These highlights do not include all the information needed to use FRAGMIN safely and effectively. See full prescribing information for FRAGMIN. FRAGMIN (dalteparin sodium) injection, USP, for subcutaneous use Initial U.S. Approval: 1994

Approved
Approval ID

23527b8b-9b28-4e6d-9751-33b143975ac7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 16, 2023

Manufacturers
FDA

Pfizer Laboratories Div Pfizer Inc

DUNS: 134489525

Products 9

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0253
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

DALTEPARIN SODIUMActive
Quantity: 2500 [iU] in 1 mL
Code: 12M44VTJ7B
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0223
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

DALTEPARIN SODIUMActive
Quantity: 15000 [iU] in 0.6 mL
Code: 12M44VTJ7B
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0232
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

DALTEPARIN SODIUMActive
Quantity: 25000 [iU] in 1 mL
Code: 12M44VTJ7B
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 14 mg in 1 mL
Code: LKG8494WBH
Classification: IACT

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0206
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
DALTEPARIN SODIUMActive
Quantity: 7500 [iU] in 0.3 mL
Code: 12M44VTJ7B
Classification: ACTIB

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0195
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
DALTEPARIN SODIUMActive
Quantity: 2500 [iU] in 0.2 mL
Code: 12M44VTJ7B
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0220
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
DALTEPARIN SODIUMActive
Quantity: 12500 [iU] in 0.5 mL
Code: 12M44VTJ7B
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0217
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

DALTEPARIN SODIUMActive
Quantity: 10000 [iU] in 1 mL
Code: 12M44VTJ7B
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0196
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

DALTEPARIN SODIUMActive
Quantity: 5000 [iU] in 0.2 mL
Code: 12M44VTJ7B
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Dalteparin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0069-0228
Application NumberNDA020287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Dalteparin Sodium
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 15, 2022
FDA Product Classification

INGREDIENTS (3)

DALTEPARIN SODIUMActive
Quantity: 18000 [iU] in 0.72 mL
Code: 12M44VTJ7B
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fragmin - FDA Drug Approval Details